Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
Novara Mark David has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, Novara Mark David is listed as EVP & CHIEF COMMERCIAL OFFICER at TANDEM DIABETES CARE INC. Inside the rolling window, Novara Mark David reported no open-market purchases and 2 open-market sales totaling $4K in TNDM. The largest disclosed transaction in the window is a sale of 187 TNDM shares on Mar 17, 2026, worth $4K.
Companies traded
Other insiders at TNDM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Novara Mark David made?
Novara Mark David has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Novara Mark David trade?
Novara Mark David has filed SEC Form 4 disclosures for 1 company, including TNDM.
When was Novara Mark David's most recent SEC Form 4 filing?
Novara Mark David's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is Novara Mark David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Novara Mark David is listed as EVP & CHIEF COMMERCIAL OFFICER.
What is Novara Mark David's total buy and sell value in the current window?
Inside the rolling retention window, Novara Mark David bought $0 and sold $4K based on SEC Form 4 filings.
What was Novara Mark David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 187 TNDM shares on 2026-03-17, worth $4K, per SEC Form 4 filings.